Cargando…

Prevalence of undiagnosed stage 3 chronic kidney disease in France, Germany, Italy, Japan and the USA: results from the multinational observational REVEAL-CKD study

OBJECTIVES: REVEAL-CKD aims to estimate the prevalence of, and factors associated with, undiagnosed stage 3 chronic kidney disease (CKD). DESIGN: Multinational, observational study. SETTING: Data from six country-specific electronic medical records and/or insurance claims databases from five countri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tangri, Navdeep, Moriyama, Toshiki, Schneider, Markus P, Virgitti, Jean Blaise, De Nicola, Luca, Arnold, Matthew, Barone, Salvatore, Peach, Emily, Wittbrodt, Eric, Chen, Hungta, Järbrink, Krister, Kushner, Pamela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Renal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230905/ https://www.ncbi.nlm.nih.gov/pubmed/37217263 http://dx.doi.org/10.1136/bmjopen-2022-067386

Ejemplares similares

Investigating the global prevalence and consequences of undiagnosed stage 3 chronic kidney disease: methods and rationale for the REVEAL-CKD study
por: Kushner, Pamela, et al.
Publicado: (2021)

Patient Management and Clinical Outcomes Associated with a Recorded Diagnosis of Stage 3 Chronic Kidney Disease: The REVEAL-CKD Study
por: Tangri, Navdeep, et al.
Publicado: (2023)

Clinician beliefs and attitudes about home haemodialysis: a multinational interview study
por: Tong, Allison, et al.
Publicado: (2012)

Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction On Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study
por: Lioufas, Nicole, et al.
Publicado: (2019)

A cross-sectional study measuring vanadium and chromium levels in paediatric patients with CKD
por: Filler, Guido, et al.
Publicado: (2017)

Impact of quality improvement initiatives to improve CKD referral patterns: a systematic review protocol
por: Ghimire, Anukul, et al.
Publicado: (2022)

A national surveillance project on chronic kidney disease management in Canadian primary care: a study protocol
por: Bello, Aminu K, et al.
Publicado: (2017)

Characteristics, management and outcomes in patients with CKD in a healthcare region in Sweden: a population-based, observational study
por: Agvall, Björn, et al.
Publicado: (2023)

Impact of home telemonitoring and management support on blood pressure control in non-dialysis CKD: a systematic review protocol
por: Okpechi, Ikechi G, et al.
Publicado: (2021)

Nutrition and dietary intake and their association with mortality and hospitalisation in adults with chronic kidney disease treated with haemodialysis: protocol for DIET-HD, a prospective multinational cohort study
por: Palmer, Suetonia C, et al.
Publicado: (2015)

Chronic kidney disease: a large-scale population-based study of the effects of introducing the CKD-EPI formula for eGFR reporting
por: O'Callaghan, Christopher A, et al.
Publicado: (2011)

Association of serum alkaline phosphatase with mortality in non-selected European patients with CKD5D: an observational, three-centre survival analysis
por: Beige, Joachim, et al.
Publicado: (2014)

Results and lessons from the Spironolactone To Prevent Cardiovascular Events in Early Stage Chronic Kidney Disease (STOP-CKD) randomised controlled trial
por: Ng, Khai P, et al.
Publicado: (2016)

Trajectories of CKD-MBD biochemical parameters over a 2-year period following diagnosis of secondary hyperparathyroidism: a pharmacoepidemiological study
por: Filipozzi, Pierre, et al.
Publicado: (2017)

RAPID-ADPKD (Retrospective epidemiological study of Asia-Pacific patients with rapId Disease progression of Autosomal Dominant Polycystic Kidney Disease): study protocol for a multinational, retrospective cohort study
por: Ryu, Hyunjin, et al.
Publicado: (2020)

Integrating Conservative kidney management Options and advance care Planning Education (COPE) into routine CKD care: a protocol for a pilot randomised controlled trial
por: Stallings, Taylor L, et al.
Publicado: (2021)

Association between practice coding of chronic kidney disease (CKD) in primary care and subsequent hospitalisations and death: a cohort analysis using national audit data
por: Cleary, Faye, et al.
Publicado: (2022)

Conventional Risk Factors Associated With Meaningful Outcomes in Advanced CKD
por: Collister, David, et al.
Publicado: (2018)

Referral patterns, disease progression and impact of the kidney failure risk equation (KFRE) in a Queensland Chronic Kidney Disease Registry (CKD.QLD) cohort: a study protocol
por: Mutatiri, Clyson, et al.
Publicado: (2022)

Effects of Veverimer in Older Adults With CKD and Metabolic Acidosis
por: Tangri, Navdeep, et al.
Publicado: (2021)

Weekend versus weekday transplant surgery and outcomes after kidney transplantation in the USA: a retrospective national database analysis
por: Baid-Agrawal, Seema, et al.
Publicado: (2016)

Serum ionised calcium and the risk of acute respiratory failure in hospitalised patients: a single-centre cohort study in the USA
por: Thongprayoon, Charat, et al.
Publicado: (2020)

The EX-FRAIL CKD trial: a study protocol for a pilot randomised controlled trial of a home-based EXercise programme for pre-frail and FRAIL, older adults with Chronic Kidney Disease
por: Nixon, Andrew Christopher, et al.
Publicado: (2020)

Treatment decision-making and care among older adults with kidney failure: protocol for a multicentre, prospective observational cohort study with nested substudies and linked qualitative research (the Elderly Advanced CKD Programme)
por: Siriwardana, Amanda, et al.
Publicado: (2022)

Can patiromer allow for intensified renin–angiotensin–aldosterone system blockade with losartan and spironolactone leading to decreased albuminuria in patients with chronic kidney disease, albuminuria and hyperkalaemia? An open-label randomised controlled trial: MorphCKD
por: Mårup, Frederik Husum, et al.
Publicado: (2022)

Preventing renal and cardiovascular risk by renal function assessment: insights from a cross-sectional study in low-income countries and the USA
por: Cravedi, Paolo, et al.
Publicado: (2012)

Inflammatory Response to Sorbent Hemodialysis
por: Rosales, Laura, et al.
Publicado: (2015)

Dietary sodium induces a redistribution of the tubular metabolic workload
por: Udwan, Khalil, et al.
Publicado: (2017)

VEGF‐A(165)b protects against proteinuria in a mouse model with progressive depletion of all endogenous VEGF‐A splice isoforms from the kidney
por: Stevens, Megan, et al.
Publicado: (2017)

RAAS inhibitors directly reduce diabetes‐induced renal fibrosis via growth factor inhibition
por: Koszegi, Sandor, et al.
Publicado: (2018)

Metabolic Acidosis and Cardiovascular Disease in CKD
por: Collister, David, et al.
Publicado: (2021)

Metabolic Acidosis and Adverse Outcomes and Costs in CKD: An Observational Cohort Study
por: Reaven, Nancy L., et al.
Publicado: (2023)

Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol
por: Blankestijn, Peter J, et al.
Publicado: (2020)

The French Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort study
por: Stengel, Bénédicte, et al.
Publicado: (2014)

Physical Function in Adults With Metabolic Acidosis and Advanced CKD: Patient Reported Versus Assessed Physical Function
por: Tangri, Navdeep, et al.
Publicado: (2022)

Development and External Validation of a Machine Learning Model for Progression of CKD
por: Ferguson, Thomas, et al.
Publicado: (2022)

Risk of Kidney Failure, Death, and Cardiovascular Events After Lower Limb Complications in Patients With CKD
por: Li, Kevin, et al.
Publicado: (2020)

Association of Bone Mineral Density With Fractures Across the Spectrum of Chronic Kidney Disease: The Regina CKD-MBD Study
por: Prasad, Bhanu, et al.
Publicado: (2019)

Patient Navigators for CKD and Kidney Failure: A Systematic Review
por: Taha, Ali, et al.
Publicado: (2022)

Projecting the Epidemiological and Economic Impact of Chronic Kidney Disease Using Patient-Level Microsimulation Modelling: Rationale and Methods of Inside CKD
por: Tangri, Navdeep, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i1kt8purpmmibul6haf9lfduvi